Kairos Pharma’s (KAPA) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has a $9.00 target price on the stock. Kairos Pharma Stock Performance Kairos Pharma stock opened at $1.19 on Wednesday. Kairos Pharma has a fifty-two week low […]
D. Boral Capital reaffirmed their buy rating on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has a $9.00 target price on the stock. Kairos Pharma Stock Performance Kairos Pharma stock opened at $1.19 on Wednesday. Kairos Pharma has a fifty-two week low […]
